Related Experiment Video
Updated: Sep 12, 2026
A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Spleen Cell Biology and Transplant Immunity
Published on: June 11, 2019
Splenectomy in patients with hepatocellular carcinoma and hypersplenism
Y Sugawara1, J Yamamoto, K Shimada
1Department of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan.
Insights
Combined splenectomy and liver resection safely manages hepatocellular carcinoma (HCC) with hypersplenism. This approach improves platelet counts and reduces bilirubin levels, enhancing patient outcomes.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Hypersplenism is a common complication of portal hypertension in hepatocellular carcinoma (HCC).
- Managing HCC patients with hypersplenism presents significant surgical challenges.
Purpose of the Study:
- To evaluate the clinical value of combining splenectomy with liver resection in HCC patients.
- To assess the safety and efficacy of synchronous versus two-stage hepatectomy and splenectomy.
Main Methods:
- Retrospective analysis of 48 patients with HCC and hypersplenism.
- Hepatectomy and splenectomy performed either synchronously (35 patients) or staged (13 patients).
- Postoperative assessment of platelet counts, serum total bilirubin, and clinical staging scores.
Main Results:
- Significant increases in postoperative platelet counts observed.
- Significant decreases in serum total bilirubin levels reported.
- Reduced clinical staging scores in patients who underwent splenectomy prior to hepatectomy.
Conclusions:
- Combined splenectomy and hepatectomy enhance safety for selected HCC patients.
- The procedure reduces risks of bleeding complications and bilirubin overload.
- Synchronous or metachronous splenectomy is a valuable strategy in managing HCC with hypersplenism.
Background:
Hypersplenism secondary to portal hypertension is common in hepatocellular carcinoma (HCC), but surgeons still face the unresolved problem of how to manage HCC patients with hypersplenism.
Study Design:
The records of 48 patients with HCC and hypersplenism were retrospectively examined and postoperative changes in platelet counts, serum total bilirubin levels, and dinical staging scores were analyzed to evaluate the clinical value of combined splenectomy and liver resection. Hepatectomy and splenectomy were performed as a two-stage operation in 13 patients and synchronously in 35.
Results:
Postoperative platelet counts were significantly increased, and serum total bilirubin levels were significantly decreased. Clinical staging scores were also reduced after splenectomy in patients who underwent splenectomy before hepatectomy.
Conclusions:
Synchronous or metachronous splenectomy can increase the safety of hepatectomy in selected patients with HCC by reducing both the likelihood of bleeding complications and bilirubin overload.
